Clinical Trial Update: First-line Combination of Capecitabine and Oxaliplatin Plus Bevacizumab in Elderly Patients With Metastatic Colorectal Cancer

View source ↗

Summary

This clinical trial update describes a first-line combination of capecitabine, oxaliplatin, and bevacizumab for elderly patients with metastatic colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Elderly Metastatic Colorectal Cancer Patients | Status: ACTIVE_NOT_RECRUITING